Adjuvant Treatment with Alpha Interferon (IFN) for Patients at High Risk for Relapse after Allogeneic Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

被引：1
|
作者：
Bezerra, Evandro Dantas [1 ]
Radich, Jerald [2 ]
Flowers, Mary E. [2 ]
Chielins, Debbie [3 ]
Higano, Celestia [4 ]
机构：
[1] Univ Washington, Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[3] Seattle Canc Care Alliance, Oncol, Seattle, WA USA
[4] Univ Washington, Dept Med, Seattle, WA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2017.12.224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
326
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of alpha-interferon (IFN) treatment in chronic myeloid leukemia (CML)
    Liberato, NL
    Quaglini, S
    Barosi, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 272 - 272
  • [42] INTERFERON-ALPHA-2 (IFN) PLUS HYDROXYUREA FOR TREATMENT OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
    SUTTORP, M
    RISTER, M
    SCHMITZ, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 22 (05): : 358 - 359
  • [43] Treatment of Ph+ chronic myelogenous leukemia (CML) with interferon alfa 2B R(IFN)
    Murro, H
    Bezares, R
    Longordo, F
    Fuchs, CR
    Saidon, G
    Diaz, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 813 - 813
  • [44] Effect of interferon-alpha (IFN-A) therapy on bone marrow (BM) fibrosis in chronic myelogenous leukemia (CML)
    Wilhelm, M
    Ramos, CM
    OBrien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 3537 - 3537
  • [45] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
    GOLDMAN, JM
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 511 - 511
  • [46] DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF CHRONIC MYELOID-LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BMT
    CULLIS, JO
    VANRHEE, F
    CROSS, NCP
    BARRETT, AJ
    GOLDMAN, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 12 - 12
  • [47] TREATMENT OF LEUKEMIA RELAPSE AFTER ALLOGENEIC BMT WITH DONOR LEUKOCYTE INFUSIONS
    ANAGNOSTOPOULOS, A
    FASSAS, A
    SAKELLARI, I
    PAPADOPOULOS, A
    SALOUM, R
    IOANNIDOU, S
    ATHANASIADOU, A
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 853 - 853
  • [48] Alpha interferon as treatment for leukemia/lymphoma relapse after nonmyeloablative transplantation (NST)
    Ackerstein, A
    Slavin, S
    Shapira, M
    Dray, L
    Or, R
    BONE MARROW TRANSPLANTATION, 2002, 29 : S195 - S196
  • [49] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL WITH ALPHA-INTERFERON (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    SMITH, T
    OBRIEN, S
    ROBERTSON, L
    KOLLER, C
    BERAN, M
    KEATING, M
    TALPAZ, M
    BLOOD, 1993, 82 (10) : A378 - A378
  • [50] RESULTS OF RECOMBINANT ALPHA-2-C-INTERFERON THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KUHRER, I
    LINKESCH, W
    LUDWIG, H
    GISSLINGER, H
    BLUT, 1987, 55 (04): : 390 - 390
12345